Clinical Trials Logo

Clinical Trial Summary

Half or nearly half of college students with prescriptions divert their stimulant medication, and a similarly high percentage misuse their medication or use someone else's prescription. Diversion may lead students to go without needed medication to mitigate their symptoms, increasing their risk for unintentional injuries and substance use. Further, diversion perpetuates the non-medical use of prescription stimulants (NMUPS), which has become increasingly common among college students. Diversion also perpetuates medical misuse of stimulants among students with prescriptions, which is associated with poorer attention-deficit/hyperactivity disorder (AD/HD) symptom management and may increase the risk for addictive disorders. There are no evidence-based interventions targeting diversion of stimulants in college students. Being approached for one's medication is a key risk factor for diversion, as is medication non-adherence and believing NMUPS and diversion are more prevalent than they are. Accordingly, in this multi-site study, the investigators will conduct a randomized, controlled trial of 300 college-attending adults with current stimulant prescriptions to examine the preliminary efficacy and feasibility of a single-session, computer-based simulation intervention (with two booster sessions) to prevent prescription stimulant diversion and medication misuse and compare it to a placebo condition. The intervention, which is grounded in social learning theory and the theory of planned behavior uniquely engages students in interactive discussions with virtual humans to (a) learn about the actual prevalence of NMUPS and diversion and their related risks, (b) practice using refusal strategies when approached for their medication in high-risk situations, and (c) understand how to effectively communicate with prescribers and avoid medication misuse. The primary aims are to determine if the intervention reduces diversion, intentions to divert, and medication misuse, and to assess user satisfaction with the intervention. The secondary aims are to examine change in potential mechanisms of action targeted in the intervention, such as self-efficacy to resist diversion, knowledge about diversion and NMUPS, use of behavioral strategies to resist requests for one's medication, and prescriber communication. If effective, the intervention could be readily and widely disseminated to college counseling centers, psychiatrists, pediatricians, and other prescribers.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04885166
Study type Interventional
Source Trinity College
Contact Laura Holt, PhD
Phone 203-623-8470
Email Laura.Holt@trincoll.edu
Status Recruiting
Phase N/A
Start date May 4, 2021
Completion date April 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT03648684 - Examining Expectancy Challenges to Prevent Nonmedical Prescription Stimulant Use N/A
Completed NCT03947749 - Linking Epigenomics With Prescription Opioid Abuse and High Impact Musculoskeletal Pain
Active, not recruiting NCT03129334 - Preventing Prescription Drug Abuse in Middle School Students N/A
Completed NCT03286218 - A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug Users Phase 1
Completed NCT04069403 - An Opioid Prescribing Nudge N/A
Completed NCT03612713 - Influence of Medication on Functional Connectivity Early Phase 1
Completed NCT03936985 - Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool
Completed NCT03165175 - Mobile Application for Prescription Drug-Abuse Education (MAPDE) N/A
Active, not recruiting NCT03219190 - A High School Program for Preventing Prescription Drug Abuse N/A